MET and central nervous system cancer: Data from Lal et al. demonstrated that targeting the Met/HGF axis potentiates the response to γ-radiation synergistically, increases apoptosis, and attenuates cell viability in U87 MG human glioma cell lines and glioma xenograft models [68].